CASE STUDY – GLAXOSMITHKLINE – ISSUE: EXECUTIVE PAY

Our manager met the company and provided detailed feedback to the remuneration committee.

CASE STUDY – GLAXOSMITHKLINE – ISSUE: EXECUTIVE PAY

Our manager met the company and provided detailed feedback to the remuneration committee.

GlaxoSmithKline plc (“GSK”) has received negative attention on its approach to executive remuneration, mainly due to the alignment of executive pay to that of GSK’s global peers, most of which are large US pharmaceutical companies that are used to setting high pay levels.

The company reached out to its shareholders as it was preparing to renew its policy.

Our manager met the company and provided detailed feedback to the remuneration committee. It encouraged pension contributions for serving executives to be reduced to a maximum of 15% of salary, which is more closely aligned to the contribution level of the wider workforce. Following the consultation process, the company announced that the pension contribution level had been reconsidered. By 2023, it will be brought down to 7% of salary; the same as the company offers to its employees generally.

14 June 22

keep up to-date with our latest insights & media

investment risk

The value of your investments and any income from them can go down as well as up and you may not get back the original amount invested. Gearing is used for investment purposes to obtain, increase or reduce exposure to an asset, index or investment. The use of gearing can enhance returns to investors in a rising market, but if the market falls the losses may be greater.

The mention of a company does not constitute, and should not be construed as, investment advice or a recommendation to buy, sell or otherwise transact in the company.

Smart investing made simple